| Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR) |
8 |
| Diabetes epidemiology in Russia: what has changed over the decade? |
7 |
| Vitamin D deficiency and cardiovascular pathology |
6 |
| Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease |
5 |
| Atherosclerosis: perspectives of anti-inflammatory therapy |
5 |
| Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study |
4 |
| The prevalence of abdominal obesity and the association with socioeconomic status in Regions of the Russian Federation, the results of the epidemiological study - ESSE-RF |
4 |
| The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation |
4 |
| Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry |
4 |
| European Registry on the management of Helicobacter pylori infection (Hp-EuReg): n analysis of 2360 patients receiving first-line therapy in Russia |
3 |
| Intrahepatic cholestasis in nonalcoholic fatty liver disease |
3 |
| Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure |
3 |
| The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease |
3 |
| Genetic determinants of the development and course of membranous nephropathy |
3 |
| Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration |
3 |
| Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases |
3 |
| The role of presepsin in the diagnosis and assessment of severity of sepsis and severe pneumonia |
3 |
| Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage |
3 |
| Significance of L-carnitine in internal medicine |
3 |
| Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk |
2 |
| Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and:idiopathic pulmonary arterial hypertension according to the Russian registry |
2 |
| Follicular lymphoma: first-line selection criteria of treatment |
2 |
| European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years |
2 |
| Risk factors of unfavorable prognosis of chronic hepatitis C |
2 |
| Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study |
2 |
| Vitamins in diet of patients with metabolic syndrome |
2 |
| Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease |
2 |
| Case of iatrogenic botulism after botulinotherapy in clinical practice |
2 |
| Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia |
2 |
| Thrombopoietin Receptor Agonists in the Treatment of Chronic Resistant Primary Immune Thrombocytopenia: Efficacy and Safety Data in Real Clinical Practice |
2 |
| Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases |
2 |
| Vitamin D: effects on pregnancy, maternal, fetal and postnatal outcomes |
2 |
| Normoalbuminuric chronic kidney disease in diabetes |
2 |
| Quality of life of chronic kidney disease patients on renal replacement therapy |
2 |
| Cardiovascular disease and associated comorbid conditions as determinants of adverse perinatal outcomes in pregnancy - an analysis of the results of the register of pregnant BEREG |
2 |
| Features of the clinical picture in patients of middle age with essential hypertension |
2 |
| PCSK9 Inhibitor causes a decrease in the level of oxidatively modified low-density lipoproteins in patients with coronary artery diseases |
2 |
| Place of vitamin D in the prevention of premature aging and the development of age-associated diseases |
2 |
| Diagnosis of Helicobacter pylori infection in clinical practice |
2 |
| Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases |
2 |
| Diagnosis of IgG4-related ophthalmic disease in a group of patients with various lesions of the eye and orbits |
2 |
| Neurological disorders in vitamin B-12 deficiency |
1 |
| Diagnostic difficulties of primary hemochromatosis in a patient with posthemorrhagic anemia |
1 |
| Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat |
1 |
| Biochemical and molecular-genetic indicators of inflammation and apoptosis in liver cirrhosis as an outcome of the progression of non-alcoholic steatohepatitis |
1 |
| The clinical status and treatment options for osteoarthritis in patients with frailty |
1 |
| Effect of N-acetylcysteine on mucosal immunity of respiratory tract |
1 |
| Chronic obstructive pulmonary disease and cerebrovascular diseases: functional and clinical aspect of comorbidity |
1 |
| Combination therapy is a new standard for treatment of pulmonary arterial hypertension |
1 |
| Management of acute coronary syndrome in older adults (data from russian federal acute coronary syndrome registry) |
1 |
